Targeting abnormal Nrf2/HO-1 signaling in amyotrophic lateral sclerosis: Current Insights on drug targets and influences on neurological disorders

E Minj, RK Yadav, S Mehan - Current molecular medicine, 2021 - ingentaconnect.com
The nuclear erythroid 2-related-factor (Nrf2) transcription factor/hemoxygenase 1 (HO-1) is a
key regulator of an important neuroprotection response by driving the interpretation of …
被引用次数：25 相关文章

Targeting Abnormal Nrf2/HO-1 Signaling in Amyotrophic Lateral Sclerosis: Current Insights on Drug Targets and Influences on Neurological Disorders.

E Minj, RK Yadav, S Mehan - Current Molecular Medicine, 2021 - europepmc.org
The nuclear erythroid 2-related-factor (Nrf2) transcription factor/hemoxygenase 1 (HO-1) is a
key regulator of an important neuroprotection response by driving the interpretation of …

Targeting Abnormal Nrf2/HO-1 Signaling in Amyotrophic Lateral Sclerosis: Current Insights on Drug Targets and Influences on Neurological Disorders

E Minj, RK Yadav, S Mehan - Current molecular medicine, 2021 - pubmed.ncbi.nlm.nih.gov
The nuclear erythroid 2-related-factor (Nrf2) transcription factor/hemoxygenase 1 (HO-1) is a
key regulator of an important neuroprotection response by driving the interpretation of …